RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
Liquidia begins testing flu vaccine
Liquidia Technologies has started early clinical testing of its first vaccine developed using nanotechnology.
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.